APA (7th ed.) Citation

El-Dakroury, W. A., Salim, S. A., Said, A. R., Asaad, G. F., Abdelhameed, M. F., Shabana, M. E., . . . El-Tokhy, F. S. (2026). Novel Repurposing of Empagliflozin-Loaded Buccal Composite (Chitosan/Silk Fibroin/Poly(lactic acid)) Nanofibers for Alzheimer's Disease Management via Modulation of Aβ–AGER–p-tau Pathway. Pharmaceutics, 18(1), 83. https://doi.org/10.3390/pharmaceutics18010083

Chicago Style (17th ed.) Citation

El-Dakroury, Walaa A., et al. "Novel Repurposing of Empagliflozin-Loaded Buccal Composite (Chitosan/Silk Fibroin/Poly(lactic Acid)) Nanofibers for Alzheimer's Disease Management via Modulation of Aβ–AGER–p-tau Pathway." Pharmaceutics 18, no. 1 (2026): 83. https://doi.org/10.3390/pharmaceutics18010083.

MLA (9th ed.) Citation

El-Dakroury, Walaa A., et al. "Novel Repurposing of Empagliflozin-Loaded Buccal Composite (Chitosan/Silk Fibroin/Poly(lactic Acid)) Nanofibers for Alzheimer's Disease Management via Modulation of Aβ–AGER–p-tau Pathway." Pharmaceutics, vol. 18, no. 1, 2026, p. 83, https://doi.org/10.3390/pharmaceutics18010083.